Gane E. Safety and Efficacy at 1 year after Switching from Tenofovir Disoproxil Fumurate to Tenofovir Alafenamide in Chronic HBV Patients with Risk Factors for TDF Use. PS-156.
Adequate humorale respons op SARS-CoV-2-infectie na levertransplantatie
jan 2022 | Hepatologie, Virale infecties